The molecular basis of hepcidin-resistant hereditary hemochromatosis

Blood

Volumn 114, Issue 2, 2009, Pages 437-443

  Fernandes, Augustine ^a   Preza, Gloria C ^a   Phung, Yen ^a   De Domenico, Ivana ^b   Kaplan, Jerry ^b   Ganz, Tomas ^a   Nemeth, Elizabeta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; HEPCIDIN; ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; IRON; LIGAND; METAL TRANSPORTING PROTEIN 1; THIOL DERIVATIVE;

ARTICLE; BINDING SITE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; CELL LINE; CELL MEMBRANE; GENETICS; METABOLISM; MUTATION;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; CELL LINE; CELL MEMBRANE; HEMOCHROMATOSIS; HUMANS; IRON; LIGANDS; MUTATION; PROTEIN BINDING; SULFHYDRYL COMPOUNDS;

EID: 67651087324     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-146134     Document Type: Article

References (27)

1. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program. 2006;507:29-35.
2. Donovan A, Lima CA, Pinkus JL, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1:191-200. (Pubitemid 43960600)
3. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093. (Pubitemid 40007660)
4. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-342.
5. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000; 403:776-781. (Pubitemid 30111839)
6. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis. 2004;32:131-138.
7. Schimanski LM, Drakesmith H, Merryweather- Clarke AT, et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosisassociated FPN mutations. Blood. 2005;105: 4096-4102. (Pubitemid 40656160)
8. De Domenico I, Ward DM, Nemeth E, et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A. 2005;102: 8955-8960.
9. Liu XB, Yang F, Haile DJ. Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis. 2005;35:33-46.
10. Goncalves AS, Muzeau F, Blaybel R, et al. Wildtype and mutant ferroportins do not form oligomers in transfected cells. Biochem J. 2006; 396:265-275. (Pubitemid 43837242)
11. Drakesmith H, Schimanski LM, Ormerod E, et al. Resistance to hepcidin is conferred by hemochromatosis- associated mutations of ferroportin. Blood. 2005;106:1092-1097. (Pubitemid 41076459)
12. Wallace DF, Clark RM, Harley HAJ, Subramaniam VN. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. J Hepatol. 2004;40:710-713.
13. Viprakasit V, Merryweather-Clarke AT, Chinthammitr Y, et al. Molecular diagnosis of the first ferroportin mutation (C326Y) in the Far East causing a dominant form of inherited iron overload [abstract]. Blood. 2004;104:Abstract 3204.
14. Lok CY, Merryweather-Clarke AT, Viprakasit V, et al. Iron overload in the Asian community. Blood. 2009;114:20-25.
15. Arden KE, Wallace DF, Dixon JL, et al. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut. 2003;52:1215-1217. (Pubitemid 36877439)
16. Rivard SR, Lanzara C, Grimard D, et al. Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family. Haematologica. 2003; 88:824-826. (Pubitemid 36896141)
17. Sham RL, Phatak PD, West C, et al. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis. 2005;34: 157-161. (Pubitemid 40250491)
18. Sham RL, Phatak PD, Nemeth E, Ganz T. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation [letter]. Blood. 2009; 114:493-494.
19. Rivera S, Nemeth E, Gabayan V, et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106:2196-2199. (Pubitemid 41291740)
20. De Domenico I, Ward DM, Langelier C, et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 2007;18: 2569-2578. (Pubitemid 47025722)
21. Jordan PA, Gibbins JM. Extracellular disulfide exchange and the regulation of cellular function. Antioxid Redox Signal. 2006;8:312-324. (Pubitemid 43741302)
22. De Domenico I, Ward DM, di Patti MC, et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26:2823-2831. (Pubitemid 46975784)
23. Pietrangelo A, Montosi G, Totaro A, et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med. 1999;341:725-732. (Pubitemid 29407372)
24. Montosi G, Donovan A, Totaro A, et al. Autosomal- dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108:619-623. (Pubitemid 32777742)
25. De Domenico I, McVey WD, Nemeth E, et al. Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica. 2006;91:1092-1095. (Pubitemid 44204775)
26. Zhang AS, Xiong S, Tsukamoto H, Enns CA. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood. 2004;103:1509-1514. (Pubitemid 38168670)
27. Craven CM, Alexander J, Eldridge M, et al. Tissue distribution and clearance kinetics of nontransferrin- bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci U S A. 1987;84:3457-3461. (Pubitemid 17085423)